Clinical Trial Update: Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC

View source ↗

Summary

A clinical trial is evaluating a cfDNA 5mC/5hmC-based biomarker panel to predict targeted therapy efficacy in metastatic colorectal cancer and is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: City of Hope Medical Center | Conditions: CRC (Colorectal Cancer) | Status: RECRUITING